Through the subgroup analysis, a history of coronary artery disease (HR 2.73; CI 1.01–7.41; P = .049) remained an independent risk factor for 3-year MACE in patients with elevated cTnI levels. This evidence concerns the gene TNNI3 and coronary artery disorder.